Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 5 mg + 850 mg, 12.5 mg + 850 mg
Send MessageEmpagliflozin & Metformin HCl Tablets are a scientifically developed fixed-dose combination designed to deliver comprehensive glycemic control in patients with type 2 diabetes mellitus. This formulation combines Empagliflozin, an SGLT2 inhibitor that promotes urinary glucose excretion, with Metformin HCl, a well-established biguanide that decreases hepatic glucose production and enhances insulin sensitivity.
This dual-action approach not only improves blood glucose levels but also contributes to weight management and cardiovascular risk reduction. The combination is widely recommended in patients who require intensified therapy beyond monotherapy, making it a key component in modern diabetes and cardiometabolic care strategies.
Genliva Wellness LLP, Himatnagar, India, is a reliable empagliflozin metformin tablet manufacturer India pharma and combination antidiabetic tablets exporter India, supplying high-quality, WHO-GMP compliant formulations to hospitals, endocrinology clinics, pharmacies, and international pharmaceutical markets.
Empagliflozin & Metformin HCl Tablets combine an SGLT2 inhibitor with a biguanide antidiabetic agent to provide effective blood glucose control in type 2 diabetes management. The combination helps improve insulin sensitivity and reduce excess glucose levels.
These tablets are commonly used for the treatment of type 2 diabetes mellitus along with diet and exercise. They help improve glycemic control and support overall metabolic health.
Empagliflozin & Metformin HCl Tablets provide dual-action glucose control with improved metabolic support and patient convenience for effective diabetes management.
